Carisma TherapeuticsCARM

13F holders, Q3 2024 (September 30)
37holders −16
2new positions
19sold out
2famous investors
$0.98avg. 13F price*

At the end of Q3 2024, 37 institutions reported holding Carisma Therapeutics Inc. (CARM) in their 13F filings, down 16 from Q2 2024. 2 opened new positions and 19 sold out. The largest holders were Vanguard Group Inc. ($1.4M), Trustees of the University of Pennsylvania ($1.2M) and TPG GP A, LLC ($551K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Carisma Therapeutics Inc.
CUSIP
14216R101
Latest filing quarter
Q2 2026

History

Number of 13F holders

0204060 Q1 2024: 51Q1 2024Q2 2024: 53Q2 2024Q3 2024: 37Q3 2024Q4 2024: 41Q4 2024Q1 2025: 37Q1 2025Q2 2025: 36Q2 2025Q3 2025: 33Q3 2025Q4 2025: 7Q4 2025Q1 2026: 3Q1 2026Q2 2026: 1Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions2$34K
Exits19$1.0M

All 13F filers, Q2 2024 → Q3 2024: 671,193 shares bought and 1,272,767 shares sold, net −601,574 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 37 holders

Vanguard Group Inc. 0.00% No change 1,448,247 $1.4M
Trustees of the University of Pennsylvania 4.36% No change 1,252,107 $1.2M
TPG GP A, LLC 0.01% Reduce -33.3% 561,442 $551K
Barclays PLC 0.00% Add +3661933.3% 549,305 $539K
BlackRock, Inc. 0.00% — 408,564 $401K
Geode Capital Management, LLC 0.00% Reduce -8.6% 259,184 $254K
Renaissance Technologies 0.00% Add +48.4% 206,757 $203K
Millennium Management 0.00% Reduce -10.9% 142,522 $140K
State Street Corp. 0.00% No change 85,106 $84K
Northern Trust Corp. 0.00% Reduce -66.4% 75,451 $74K
Wexford Capital LP 0.01% Add +75.5% 34,861 $34K
Two Sigma Investments, LP 0.00% New 34,141 $34K
Bridgeway Capital Management, LLC 0.00% Add +5.1% 30,438 $30K
Empowered Funds, LLC 0.00% Add +5.1% 30,438 $30K
Blodgett Wealth Advisors, LLC 0.02% Reduce -2.0% 25,001 $25K
Qube Research & Technologies Ltd 0.00% Reduce -47.6% 16,584 $16K
Stratos Wealth Partners, LTD. 0.00% No change 12,200 $12K
Bank of America Corp. 0.00% Reduce -82.8% 7,281 $7K
Morgan Stanley 0.00% Reduce -73.9% 5,685 $6K
Federated Hermes, Inc. 0.00% Add +50.1% 4,973 $5K
Tower Research Capital LLC (TRC) 0.00% Reduce -71.9% 4,524 $4K
Catalyst Funds Management Pty Ltd 0.00% No change 3,900 $4K
Group One Trading LLC 0.00% No change 2,230 $2K
JPMorgan Chase & Co. 0.00% No change 921 $904
FMR LLC 0.00% Reduce -98.0% 736 $722
Bank & Trust Co 0.00% No change 525 $515
Earned Wealth Advisors, LLC 0.00% New 500 $491
Peoples Bank 0.00% No change 250 $245
UBS Group AG 0.00% Reduce -2.7% 218 $214
IFP Advisors, Inc 0.00% No change 206 $203
ORG Partners LLC 0.00% No change 200 $196
National Bank of Canada 0.00% Add +230.0% 165 $162
Nisa Investment Advisors, LLC 0.00% Add +705.0% 161 $158
Osaic Holdings, Inc. 0.00% No change 142 $139
Harbour Investments, Inc. 0.00% No change 37 $36
Citigroup Inc. 0.00% Reduce -99.7% 10 $10
Mfa Wealth Advisors, LLC 0.00% No change 8 $8

"% of holder's portfolio" is CARM's weight in each manager's 13F, not the share of Carisma Therapeutics Inc. the manager owns.